Assessment of the effect of mindfulness monotherapy on sexual dysfunction symptoms and sex-related quality of life in women.
female sexual dysfunctions
mindfulness
sexual therapy
Journal
Sexual medicine
ISSN: 2050-1161
Titre abrégé: Sex Med
Pays: England
ID NLM: 101631053
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
02
07
2022
revised:
05
04
2023
accepted:
07
04
2023
medline:
8
6
2023
pubmed:
8
6
2023
entrez:
8
6
2023
Statut:
epublish
Résumé
Mindfulness-based therapies (MBTs) are frequently used in the treatment of sexual dysfunctions. So far, there has not been sufficient evidence for the effectiveness of interventions based on mindfulness monotherapy. The aim of the study was to assess the effect of mindfulness monotherapy on the reduction of sexual dysfunction symptoms and sex-related quality of life. We conducted 4 weeks of MBT for 2 groups of heterosexual females: 1 with psychogenic sexual dysfunction (WSD) and 1 with no sexual dysfunction (NSD). Overall 93 women were recruited for the study. We collected data via an online survey regarding sexual satisfaction, sexual dysfunctions, and mindfulness-related features at baseline, 1 week after MBT, and follow-up 12 weeks after MBT. Research tools included the Female Sexual Function Index, Five Facet Mindfulness Questionnaire, and Sexual Satisfaction Questionnaire. Participating in the mindfulness program had a positive effect on women with and without sexual dysfunction. The overall risk for sexual dysfunction decreased from 90.6% at baseline to 46.7% at follow-up in the WSD group and from 32.5% at baseline to 6.9% at follow-up in the NSD group. Participants in the WSD group reported a significant increase in levels of sexual desire, arousal, lubrication, and orgasm between measurements, although not in the pain domain. Participants in the NSD group reported a significant increase in the level of sexual desire between measurements but not in levels of arousal, lubrication, orgasm, and pain. A significant increase in sex-related quality of life was observed in both groups. The results of the study have a chance to translate into an introduction of a new therapeutic program for specialists and more effective help offered to women experiencing sexual dysfunctions. This mindfulness monotherapy research project, which included assessment of meditation "homework," is the first to verify the potential of MBT in reducing symptoms of psychogenic sexual dysfunctions among heterosexual females. Major limitations include the lack of randomization, an adequate control group, and a validated measure of sexual distress. The applied training was beneficial in the treatment of sexual dysfunctions in terms of increasing desire and arousal as well as the ability to reach orgasm. However, this approach needs more investigation before it can be recommended in the treatment of sexual dysfunction. The study should be replicated under a more rigorous research design, including adequate control groups and random allocation of participants to study conditions.
Sections du résumé
Background
UNASSIGNED
Mindfulness-based therapies (MBTs) are frequently used in the treatment of sexual dysfunctions. So far, there has not been sufficient evidence for the effectiveness of interventions based on mindfulness monotherapy.
Aim
UNASSIGNED
The aim of the study was to assess the effect of mindfulness monotherapy on the reduction of sexual dysfunction symptoms and sex-related quality of life.
Methods
UNASSIGNED
We conducted 4 weeks of MBT for 2 groups of heterosexual females: 1 with psychogenic sexual dysfunction (WSD) and 1 with no sexual dysfunction (NSD). Overall 93 women were recruited for the study. We collected data via an online survey regarding sexual satisfaction, sexual dysfunctions, and mindfulness-related features at baseline, 1 week after MBT, and follow-up 12 weeks after MBT. Research tools included the Female Sexual Function Index, Five Facet Mindfulness Questionnaire, and Sexual Satisfaction Questionnaire.
Outcomes
UNASSIGNED
Participating in the mindfulness program had a positive effect on women with and without sexual dysfunction.
Results
UNASSIGNED
The overall risk for sexual dysfunction decreased from 90.6% at baseline to 46.7% at follow-up in the WSD group and from 32.5% at baseline to 6.9% at follow-up in the NSD group. Participants in the WSD group reported a significant increase in levels of sexual desire, arousal, lubrication, and orgasm between measurements, although not in the pain domain. Participants in the NSD group reported a significant increase in the level of sexual desire between measurements but not in levels of arousal, lubrication, orgasm, and pain. A significant increase in sex-related quality of life was observed in both groups.
Clinical Implications
UNASSIGNED
The results of the study have a chance to translate into an introduction of a new therapeutic program for specialists and more effective help offered to women experiencing sexual dysfunctions.
Strengths and Limitations
UNASSIGNED
This mindfulness monotherapy research project, which included assessment of meditation "homework," is the first to verify the potential of MBT in reducing symptoms of psychogenic sexual dysfunctions among heterosexual females. Major limitations include the lack of randomization, an adequate control group, and a validated measure of sexual distress.
Conclusion
UNASSIGNED
The applied training was beneficial in the treatment of sexual dysfunctions in terms of increasing desire and arousal as well as the ability to reach orgasm. However, this approach needs more investigation before it can be recommended in the treatment of sexual dysfunction. The study should be replicated under a more rigorous research design, including adequate control groups and random allocation of participants to study conditions.
Identifiants
pubmed: 37287733
doi: 10.1093/sexmed/qfad022
pii: qfad022
pmc: PMC10243933
doi:
Types de publication
Journal Article
Langues
eng
Pagination
qfad022Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society of Sexual Medicine.
Références
J Consult Clin Psychol. 1986 Apr;54(2):140-8
pubmed: 3700800
J Clin Psychol. 2020 Sep;76(9):1631-1652
pubmed: 31981226
J Sex Marital Ther. 2002 Jul-Sep;28(4):317-30
pubmed: 12082670
J Sex Res. 2005 May;42(2):113-8
pubmed: 16123841
Arch Sex Behav. 2009 Oct;38(5):842-51
pubmed: 19191018
Front Psychol. 2017 Mar 06;8:220
pubmed: 28321194
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208
pubmed: 10782451
J Sex Med. 2013 Feb;10(2):386-95
pubmed: 23211010
Womens Health (Lond). 2013 May;9(3):251-63
pubmed: 23638781
J Patient Rep Outcomes. 2021 Sep 24;5(1):100
pubmed: 34559353
Behav Res Ther. 2017 Aug;95:29-41
pubmed: 28527330
Arch Sex Behav. 2003 Jun;32(3):279-85
pubmed: 12807300
J Sex Med. 2014 Nov;11(11):2709-19
pubmed: 25131552
J Clin Psychol. 2006 Mar;62(3):373-86
pubmed: 16385481
J Sex Med. 2020 Nov;17(11):2220-2228
pubmed: 32896501
Obstet Gynecol Clin North Am. 2011 Sep;38(3):425-40
pubmed: 21961711
J Sex Res. 2006 Feb;43(1):68-75
pubmed: 16817069
Anthropol Anz. 2018 Aug 27;75(3):185-191
pubmed: 29892777
J Clin Psychiatry. 1988 Oct;49 Suppl:21-5
pubmed: 3170497
J Sex Med. 2017 Dec;14(12):1463-1491
pubmed: 29198504
J Sex Med. 2010 Jul;7(7):2458-68
pubmed: 20456625
Womens Midlife Health. 2021 Sep 17;7(1):8
pubmed: 34535191
Front Hum Neurosci. 2012 Oct 25;6:296
pubmed: 23112770
Arch Sex Behav. 2002 Oct;31(5):451-5
pubmed: 12238614
Int J Impot Res. 2013 Mar-Apr;25(2):51-5
pubmed: 23151594
J Sex Res. 2017 Sep;54(7):850-861
pubmed: 27712106
Arch Sex Behav. 2016 Nov;45(8):1907-1921
pubmed: 26919839
J Sex Med. 2016 Dec;13(12):1907-1914
pubmed: 27789208
Arch Sex Behav. 2016 Nov;45(8):2029-2045
pubmed: 25787208
Psychosom Med. 2011 Nov-Dec;73(9):817-25
pubmed: 22048839
Mindfulness (N Y). 2018;9(3):673-692
pubmed: 29875880
Arch Sex Behav. 2019 Feb;48(2):481-494
pubmed: 30671876
J Sex Marital Ther. 2000 Jan-Mar;26(1):51-65
pubmed: 10693116
J Sex Marital Ther. 2016 Jul 3;42(5):448-61
pubmed: 26098130
J Sex Res. 2017 Sep;54(7):832-849
pubmed: 28617103
J Sex Marital Ther. 2018 May 19;44(4):398-409
pubmed: 29166215
PLoS One. 2017 Oct 11;12(10):e0185979
pubmed: 29020067
J Sex Marital Ther. 2019;45(6):497-509
pubmed: 30714489
Can J Psychiatry. 2012 Feb;57(2):70-7
pubmed: 22340146
Clin Psychol Rev. 2011 Aug;31(6):1041-56
pubmed: 21802619
J Sex Marital Ther. 2022;48(4):323-342
pubmed: 34693896
J Sex Med. 2019 Oct;16(10):1581-1596
pubmed: 31570137
J Sex Res. 2014;51(1):22-30
pubmed: 24070214
Gynecol Oncol. 2012 May;125(2):320-5
pubmed: 22293042
Arab J Urol. 2013 Sep;11(3):299-304
pubmed: 26558096
J Sex Marital Ther. 2017 Nov 17;43(8):801-810
pubmed: 28368683
Menopause. 2018 Oct;25(10):1094-1104
pubmed: 29916947
CMAJ. 2005 May 10;172(10):1327-33
pubmed: 15883409
Int J Endocrinol. 2014;2014:847871
pubmed: 24707290
J Sex Med. 2016 Sep;13(9):1387-1394
pubmed: 27444158
Sex Med Rev. 2019 Apr;7(2):223-250
pubmed: 29402732
J Sex Med. 2010 Jan;7(1 Pt 2):327-36
pubmed: 20092442
World Psychiatry. 2017 Oct;16(3):245-246
pubmed: 28941087
J Sex Med. 2014 Apr;11(4):942-955
pubmed: 23859298
Arch Sex Behav. 2022 Jan;51(1):547-564
pubmed: 34997399
J Behav Addict. 2018 Dec 1;7(4):917-929
pubmed: 30580543
J Sex Med. 2015 Jan;12(1):189-97
pubmed: 25311333
J Sex Med. 2020 Jan;17(1):17-25
pubmed: 31735616
J Sex Res. 2009 Mar-Jun;46(2-3):237-48
pubmed: 19308846
World Psychiatry. 2016 Oct;15(3):205-221
pubmed: 27717275
Acta Psychiatr Scand. 2011 Aug;124(2):102-19
pubmed: 21534932
Arch Sex Behav. 2021 Aug;50(6):2589-2602
pubmed: 34405307
Glob Adv Health Med. 2022 Jan 27;11:21649561211068805
pubmed: 35127272
J Sex Res. 2018 May -Jun;55(4-5):563-581
pubmed: 29521522
Assessment. 2008 Sep;15(3):329-42
pubmed: 18310597
J Behav Med. 2008 Feb;31(1):23-33
pubmed: 17899351
Womens Health (Lond). 2018 Jan-Dec;14:1745506518762664
pubmed: 29649948
J Psychiatr Pract. 2021 May 5;27(3):212-223
pubmed: 33939376
J Sex Marital Ther. 2012;38(1):1-27
pubmed: 22268979
J Sex Med. 2016 Apr;13(4):538-71
pubmed: 27045257